Repinotan

Repinotan
Klinički podaci
Način primeneOralno
Pravni status
Pravni status
  • Nije kontrolisana supstanca
Identifikatori
CAS broj144980-29-0 Зелена квачицаДа
ATC kodnone
PubChemCID 198757
UNII05PB82Z52L Зелена квачицаДа
ChEMBLCHEMBL1614652 Зелена квачицаДа

Repinotan (BAYx3702) je selektivni pun agonist 5-HT1A receptor visoke potentnosti i efikasnosti.[1][2] On ima neuroprotektivno dejstvo u životinjskim studijama,[3][4][5] i bio je u kliničkim ispitivanjima za primenu u redukovanju oštećenja mozga nakon povrede glave.[6] Naknadno je ispitivan u fazi II za tretman moždanog udara. Dok su nuspojave bile blage i sastojale se uglavnom od mučnine, repinotan nije bio dovoljno efikasan da bi se opravdala dalja klinička ispitivanja.[7][8][9]

Repinotan se i dalje istražuje za druge moguće primene. Utvrđeno je da je efektivan za tretiranje respiratorne depresije proizvedene morfinom, mada u proizvodi malo umanjenje analgetskog dejstva.[10]

Reference

  1. ^ De Vry, J.; Schohe-Loop, R.; Heine, H. G.; Greuel, J. M.; Mauler, F.; Schmidt, B.; Sommermeyer, H.; Glaser, T. (1998). „Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist”. The Journal of Pharmacology and Experimental Therapeutics. 284 (3): 1082—1094. PMID 9495870. 
  2. ^ Dong, J.; De Montigny, C.; Blier, P. (1998). „Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe”. The Journal of Pharmacology and Experimental Therapeutics. 286 (3): 1239—1247. PMID 9732384. 
  3. ^ Alessandri, B.; Tsuchida, E.; Bullock, R. M. (1999). „The neuroprotective effect of a new serotonin receptor agonist, BAY X3702, upon focal ischemic brain damage caused by acute subdural hematoma in the rat”. Brain Research. 845 (2): 232—235. PMID 10536203. doi:10.1016/S0006-8993(99)01948-4. 
  4. ^ Kline, A. E.; Yu, J.; Horváth, E.; Marion, D. W.; Dixon, C. E. (2001). „The selective 5-HT(1A) receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats”. Neuroscience. 106 (3): 547—555. PMID 11591455. doi:10.1016/S0306-4522(01)00300-1. 
  5. ^ Mauler, F.; Horváth, E. (2005). „Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury”. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 25 (4): 451—459. PMID 15674237. doi:10.1038/sj.jcbfm.9600038. 
  6. ^ Ohman, J.; Braakman, R.; Legout, V.; Traumatic Brain Injury Study Group (2001). „Repinotan (BAY x 3702): a 5HT1A agonist in traumatically brain injured patients”. Journal of neurotrauma. 18 (12): 1313—1321. PMID 11780862. doi:10.1089/08977150152725614. 
  7. ^ Lutsep, H. L. (2005). „Repinotan, A 5-HT1A agonist, in the treatment of acute ischemic stroke”. Current drug targets. CNS and neurological disorders. 4 (2): 119—120. PMID 15857296. doi:10.2174/1568007053544165. 
  8. ^ Berends, A. C.; Luiten, P. G.; Nyakas, C. (2005). „A review of the neuroprotective properties of the 5-HT1A receptor agonist repinotan HCl (BAYx3702) in ischemic stroke”. CNS Drug Reviews. 11 (4): 379—402. PMID 16614737. doi:10.1111/j.1527-3458.2005.tb00055.x. 
  9. ^ Teal, P.; Davis, S.; Hacke, W.; Kaste, M.; Lyden, P.; Modified Randomized Exposure Controlled Trial Study Investigators; Fierus, M.; Bayer Healthcare, A. (2009). „A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT)”. Stroke; a journal of cerebral circulation. 40 (11): 3518—3525. PMID 19745176. doi:10.1161/STROKEAHA.109.551382. 
  10. ^ Guenther U, Wrigge H, Theuerkauf N, Boettcher MF, Wensing G, Zinserling J, Putensen C, Hoeft A (2010). „Repinotan, a selective 5-HT1A-R-agonist, antagonizes morphine-induced ventilatory depression in anesthetized rats”. Anesthesia and Analgesia. 111 (4): 901—7. PMID 20802053. doi:10.1213/ANE.0b013e3181eac011. 

Vidi još

Spoljašnje veze

Repinotan на Викимедијиној остави.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.